Review of: Allemang, Dean and Hendler, James. Semantic Web for the working ontologist: modeling in RDF, RDFS and OWL. Burlington, MA: Morgan Kaufmann, 2008

T. Brooks

Abstract:

What problem does this paper attempt to address?

Oral Appliance Treatment for Obstructive Sleep Apnea: An Update

Kate Sutherland,Olivier M Vanderveken,Hiroko Tsuda,Marie Marklund,Frederic Gagnadoux,Clete A Kushida,Peter A Cistulli,Olivier M. Vanderveken,Clete A. Kushida,Peter A. Cistulli

DOI: https://doi.org/10.5664/jcsm.3460

2014-02-15

Journal of Clinical Sleep Medicine

Abstract:Oral appliances (OA) have emerged as an alternative to continuous positive airway pressure (CPAP) for obstructive sleep apnea (OSA) treatment. The most commonly used OA reduces upper airway collapse by advancing the mandible (OAm). There is a strong evidence base demonstrating OAm improve OSA in the majority of patients, including some with more severe disease. However OAm are not efficacious for all, with approximately one-third of patients experiencing no therapeutic benefit. OAm are generally well tolerated, although short-term adverse effects during acclimatization are common. Long-term dental changes do occur, but these are for the most part subclinical and do not preclude continued use. Patients often prefer OAm to gold-standard CPAP treatment. Head-to-head trials confirm CPAP is superior in reducing OSA parameters on polysomnography; however, this greater efficacy does not necessarily translate into better health outcomes in clinical practice. Comparable effectiveness of OAm and CPAP has been attributed to higher reported nightly use of OAm, suggesting that inferiority in reducing apneic events may be counteracted by greater treatment adherence. Recently, significant advances in commercially available OAm technologies have been made. Remotely controlled mandibular positioners have the potential to identify treatment responders and the level of therapeutic advancement required in single night titration polysomnography. Objective monitoring of OAm adherence using small embedded temperature sensing data loggers is now available and will enhance clinical practice and research. These technologies will further enhance efficacy and effectiveness of OAm treatment for OSA.

clinical neurology
Theory of zeta potential measurement

P. Sides

Abstract:
Evaluation of Orthodontic Treatment Modalities for Obstructive Sleep Apnoea: A Systematic Review

Praveen Kumar Gorikapudi,Vedant Chhabria,Kirandeep Kaur,Padmanathan Ramasamy,Sherin Jeeboy,Rohini Venkatesh,Aishwarrya P

DOI: https://doi.org/10.7759/cureus.65161

2024-07-22

Cureus

Abstract:Obstructive sleep apnoea (OSA) poses a significant health burden globally, necessitating effective intervention strategies to mitigate its adverse consequences. Orthodontic treatment modalities offer promising avenues for addressing OSA by targeting the underlying anatomical abnormalities and restoring unobstructed airflow during sleep. This systematic search was conducted across multiple electronic databases using predefined search terms and inclusion criteria. Studies eligible for inclusion encompassed a range of study designs, including randomized controlled trials, prospective and retrospective studies, clinical trials, and observational studies. Outcome measures included changes in apnoea-hypopnoea index (AHI), oxygen saturation levels, polysomnographic variables, skeletal/cephalometric changes, nasal parameters, upper airway morphology, and clinical symptoms. Initially, 756 records were identified through database searches, with 21 studies meeting the inclusion criteria after meticulous screening and selection. Orthodontic interventions, including rapid maxillary expansion (RME), personalized oral appliances, mandibular positioning devices, and comprehensive orthodontic protocols, demonstrated significant promise in ameliorating OSA symptoms among paediatric populations. Improvements in AHI, nasal resistance, sleep parameters, and upper airway dimensions were consistently observed across various studies, highlighting the potential of orthodontic treatments in mitigating OSA severity. This systematic review underscores the efficacy of orthodontic treatment modalities in addressing OSA among paediatric populations. Despite certain limitations in study design and outcome measures, the review emphasizes the need for further well-designed randomized controlled trials to validate and optimize these interventions for paediatric patients with OSA. Enhanced understanding and implementation of orthodontic treatments hold promise for alleviating the burden of OSA on global health and well-being.
0607 Update on Observational Restrospective Study of the Efficacy of Oral Appliance Therapy for Obstructive Sleep Apnea

Sarah Meskill,Jacob Flores,Payton Boren,Sue Ellen Richardson,Gerard Meskill

DOI: https://doi.org/10.1093/sleep/zsae067.0607

IF: 6.313

2024-04-20

SLEEP

Abstract:Abstract Introduction Obstructive sleep apnea (OSA) affects approximately 15-30% of males and 10-15% of females in North America. While positive airway pressure (PAP) therapy remains the standard in the treatment of OSA, oral appliance therapy (OAT) has emerged as a viable non-invasive alternative. However, there are limited data on OAT efficacy published, and therefore many sleep clinicians question its efficacy. As an update to last year’s presentation, we extended our single-center consecutive chart review to 26 months to evaluate OAT efficacy. Methods A manual chart review was performed for records from 11/1/2020 to 12/20/2023. Potential charts were identified in the electronic health record by searching for prescriptions for OAT and orders for home sleep apnea tests (HSAT). If there was a test performed after the prescription was written, the chart was reviewed manually for previous test results and verified that post-OAT testing was conducted. Extracted information included age, BMI, gender, pre-OAT HSAT apnea-hypopnea index (AHI), and post-OAT HSAT AHI. The 4% desaturation criteria for AHI was used in accordance with current Medicare guidelines. A paired t-test was performed after ensuring there were no outliers and a normal distribution. Results There were 34 patients included in the analysis: 17 women, 17 men. The average age was 60.2 years (95% CI XXX), and average BMI was 29.5 (95% CI XXX). Prior to intervention, 12 patients had moderate OSA with the rest mild (average pre-OAT AHI 10). After OAT device, 2 patients had more than mild obstructive sleep apnea,18 patients had mild OSA, and the rest (14) did not have residual OSA (average post-OAT AHI 6). The results of the paired t-test showed that the mean AHI was statistically significantly different between the two groups. Conclusion The results demonstrate efficacy of OAT in treating OSA. Clinicians should consider OAT as both primary and secondary therapy for mild-to-moderate OSA. Support (if any)

neurosciences,clinical neurology
Ligand affinities in mutant metmyoglobins.

D. Biram,C. Garratt,R. Hester

DOI: https://doi.org/10.1016/0167-4838(93)90280-5

1993-04-21

Biochimica et Biophysica Acta

Abstract:
A Systematic Review of Oral Modifications Caused by the Prolonged Application of Continuous Positive Airway Pressure (CPAP) and Intraoral Appliances in Patients with Obstructive Sleep Apnea (OSA)

Niloofar Jafarimehrabady,Andrea Scribante,Patrizia Defabianis,Giuseppe Merlati,Marina Consuelo Vitale

DOI: https://doi.org/10.1155/2024/9361528

2024-02-25

BioMed Research International

Abstract:Objective. Prolonged use of oral devices as a substitute for traditional treatments has been studied in relation to the dental and skeletal changes associated with obstructive sleep apnea syndrome (OSA), which is a sleep-breathing disorder. Materials and Methods. A review of articles indexed in PubMed, Google Scholar, Cochrane Library, Scopus, Web of Sciences, and CINHAL databases in September 2022 based on MeSH-based keywords with "dental and skeletal" and "oral appliance" and "obstructive sleep apnea" was examined to ensure that the keywords alone or cross-linked, depending on which base of the searched data, were used. 16 articles out of 289 articles were included in the research, and 273 articles were excluded due to lack of study. Conclusions. CPAP treatment has limited dental or skeletal effects in short-term or long-term use. OAs and MADs show significant dental changes with prolonged use. MAS and TSD are more effective in short-term goals than CPAP. OAs' increase may cause dental and skeletal changes. MPD shows notable cephalometric alterations.

biotechnology & applied microbiology,medicine, research & experimental
Interdisciplinary Role of Orthodontist in Screening and Managing Obstructive Sleep Apnea in Children and Adults

Shankar Rengasamy Venugopalan,Veerasathpurush Allareddy,Sumit Yadav

DOI: https://doi.org/10.1016/j.cden.2024.03.005

Abstract:Obstructive sleep apnea (OSA) can affect children and adults, and, if left untreated, could have a major impact on the general and overall well-being of the patient. Dental health care providers and orthodontists have an interdisciplinary role in screening patients at risk for OSA and make a referral to establish a definitive diagnosis by a sleep physician. The gold standard of diagnostic testing is polysomnography. The adeno-tonsillar hypertrophy is the primary cause of sleep apnea in children; therefore, adeno-tonsillectomy must be the first line of treatment. Post adeno-tonsillectomy, if there is residual OSA due to underlying skeletal discrepancy, the patient may be referred to an orthodontist for appropriate management. Currently the evidence in the literature for prophylactic growth modification in children to prevent OSA is weak. In adults, the gold standard for managing OSA is Positive Airway Pressure (PAP) therapy; however, adherence to this treatment is rather low. The oral appliance (OA) therapy is an alternate for PAP intolerant patients and for mild to moderate OSA patients. The OA therapy has to be administered by a qualified dentist or orthodontist after careful examination of dental and periodontal health as well as any pre-existing joint conditions. The OA therapy could cause OA-associated malocclusion and patients have to be made aware of prior to initiating treatment. In patients with severe OSA, surgical maxilla-mandibular advancement (MMA) is highly effective.
Obstructive Sleep Apnea in Adults and Ear, Nose, and Throat (ENT) Health: A Narrative Review

Nishtha Choudhury,Prasad Deshmukh

DOI: https://doi.org/10.7759/cureus.47637

2023-10-25

Cureus

Abstract:Obstructive sleep apnea (OSA), a form of sleep-disordered breathing, is a significant health concern that leads to substantial morbidity. The collapse or occlusion of the upper airway, which results in reduced or cessation of airflow, is the pathophysiology of sleep apnea. The condition has been attributed to numerous cardiovascular, metabolic, and neuropsychological issues and carries serious health concerns. The ensuing intermittent hypoxia and sleep disruption set off a chain of physiological reactions that aid in developing endothelial dysfunction, systemic inflammation, and oxidative stress. The following line of treatment depends on the appropriate diagnosis of sleep apnea and the underlying cause. The gold standard for diagnosis is polysomnography (PSG), which assesses different physiological parameters during sleep. However, because polysomnography is expensive, patients may use more friendly screening and diagnostic testing kits, like home sleep apnea testing. The clinical symptoms and head and neck history may reveal essential risk factors. The primary objectives of management treatments for sleep apnea are to lessen symptoms, enhance sleep quality, and reduce any health concerns that may be present. It is advised to start with lifestyle changes such as quitting alcohol and sedative use, losing weight, and exercising frequently. The primary treatment for moderate to severe sleep apnea is continuous positive airway pressure (CPAP) therapy, which includes administering pressurized air to keep the airway open while you sleep. Oral appliances, positional therapy, surgery, and complementary therapies are other treatment choices that can be adapted to each patient's needs and preferences. The goal of the review is to evaluate the morphological and functional aspects of the upper airway, including the nose and throat, that influence the onset and severity of OSA. With a focus on the interaction between otorhinolaryngologists, sleep medicine specialists, and other healthcare professionals, we aim to consider how OSA affects otorhinolaryngology-related medical issues, look at any potential reciprocal relationships, and provide a summary of the interdisciplinary management strategy for OSA. We tried to analyse the various surgical and non-surgical therapy options for OSA management available in the otorhinolaryngology field for improving OSA symptoms and results.
Clinical and Research Solutions to Manage Obstructive Sleep Apnea: A Review

Fen Xia,Mohamad Sawan

DOI: https://doi.org/10.3390/s21051784

2021-03-04

Abstract:Obstructive sleep apnea (OSA), a common sleep disorder disease, affects millions of people. Without appropriate treatment, this disease can provoke several health-related risks including stroke and sudden death. A variety of treatments have been introduced to relieve OSA. The main present clinical treatments and undertaken research activities to improve the success rate of OSA were covered in this paper. Additionally, guidelines on choosing a suitable treatment based on scientific evidence and objective comparison were provided. This review paper specifically elaborated the clinically offered managements as well as the research activities to better treat OSA. We analyzed the methodology of each diagnostic and treatment method, the success rate, and the economic burden on the world. This review paper provided an evidence-based comparison of each treatment to guide patients and physicians, but there are some limitations that would affect the comparison result. Future research should consider the consistent follow-up period and a sufficient number of samples. With the development of implantable medical devices, hypoglossal nerve stimulation systems will be designed to be smart and miniature and one of the potential upcoming research topics. The transcutaneous electrical stimulation as a non-invasive potential treatment would be further investigated in a clinical setting. Meanwhile, no treatment can cure OSA due to the complicated etiology. To maximize the treatment success of OSA, a multidisciplinary and integrated management would be considered in the future.
0548 A 5-year Multi-center Real-world Study Evaluating the Effectiveness and Use of CAD/CAM 3D-printed OAT to Treat OSA

Robyn Woidtke,Frederic Gagnadoux,Jean-Daniel Kün-Darbois,Jérôme Forcioli,Claude Ferret,Robert Clavel,Benoît Griffet,Morgan Le Balc’h,Isabelle Dupuy-Bonafé,Didier Recart,Mirentchu Toubal-Biret,Jean-Arthur Micoulaud-Franchi,Martine Fortin,Mohammed Sedki,Vincent Trevillot

DOI: https://doi.org/10.1093/sleep/zsae067.0548

IF: 6.313

2024-04-20

SLEEP

Abstract:Abstract Introduction Oral appliance therapy (OAT) treats a wide range of obstructive sleep apnea (OSA). This prospective, collaborative (physician/dentist) study will assess the primary endpoint of at least a 50% reduction in baseline apnea-hypopnea index (AHI) at five years with initial objective efficacy evaluation at three to six months. The Panthera D-SAD is a CAD/CAM, 3D-printed OAT. Patient- matched for fit and comfort. Changeable rods provide the mechanism for protrusion. This study fulfills French reimbursement requirements. Methods OAT naïve individuals with an AHI 15-30 or those with an AHI ≥ 30 who decline CPAP will be considered, meeting all other entry criteria. Fifteen centers in France will enroll an estimated 217 participants. Consecutive sampling will be used. Participants will be medically and dentally evaluated. The initial fitting will be at Visit 1 (V1). Standard of care for the study duration will be followed. Evaluation time points are three-six months (sleep testing/medical), six months (dental), and five years (both). Secondary endpoints include OAT side effects, oxygenation status, quality of life, self-reported adherence, and subjective symptoms at the aforementioned time points. Results Between April, 2022, and December, 2023, 171 subjects have had their sleep and orthosis evaluation for entry into the study (V0). The demographics for those who have completed V0 (n=171): averages (SD) age 49.7 (13.0); BMI 26.75 (4.81); baseline AHI of 22.2 (8.7), ODI 17.16 (11.92), SpO2 91.7 (2.18). This update summarizes data from the subset (n=76) with sleep testing (V2). At baseline, 92% of participants had moderate OSA. Sixty-three percent of all participants achieved at least a 50% AHI reduction. Sixty-two percent achieved an AHI < 10. At V2, 84% severe and 87% moderate transitioned to a lower severity category. For moderate, 21% reached the normal category. Eighty-seven percent reported weekly use at V2 (n=62) for seven nights/week, and 97% indicated they used the device for ≥ 4 hours a night. Only 2.3% of participants stopped wearing the device. Conclusion This updated data demonstrates a high OAT acceptance and comfort rate for patients. Preliminary data are tracking well for reducing total AHI and migrating to a less severe AHI category. Support (if any) Panthera Dental Inc

neurosciences,clinical neurology
Orthodontics and Obstructive Sleep Apnea: A Comprehensive Study of Airway Effects and Treatment Approaches

Justine Brian

DOI: https://doi.org/10.56397/jimr/2023.12.07

2023-12-01

Abstract:This comprehensive review explores the intricate relationship between orthodontics and obstructive sleep apnea (OSA) over the past decade, with a particular focus on studies conducted in the United Kingdom. The paper synthesizes findings regarding the airway effects of orthodontic interventions, the role of various orthodontic appliances, and their effectiveness in managing OSA symptoms. The literature review encompasses investigations into changes in airway dimensions, soft tissue structures, and breathing patterns resulting from orthodontic treatments. The effectiveness of appliances like mandibular advancement devices and palatal expanders is critically examined. The challenges and limitations in studying this relationship are discussed, addressing issues related to study design, sample sizes, and variability in orthodontic techniques.
Exploring hypoglossal nerve stimulation therapy for obstructive sleep apnea: A comprehensive review of clinical and physiological upper airway outcomes

Marie-Michèle Serghani,Clemens Heiser,Alan R. Schwartz,Jason Amatoury

DOI: https://doi.org/10.1016/j.smrv.2024.101947

IF: 11.401

2024-05-24

Sleep Medicine Reviews

Abstract:Obstructive sleep apnea (OSA) is a chronic disorder characterized by recurrent episodes of upper airway collapse during sleep, which can lead to serious health issues like cardiovascular disease and neurocognitive impairments. While positive airway pressure serves as the standard treatment, intolerance in some individuals necessitates exploration of alternative therapies. Hypoglossal nerve stimulation (HGNS) promises to mitigate OSA morbidity by stimulating the tongue muscles to maintain airway patency. However, its effectiveness varies, prompting research for optimization. This review summarizes the effects of HGNS on upper airway obstruction from human and animal studies. It examines physiological responses including critical closing pressure, maximal airflow, nasal and upper airway resistance, compliance, stiffness, and geometry. Interactions among these parameters and discrepant findings in animal and human studies are explored. Additionally, the review summarizes the impact of HGNS on established OSA metrics, such as the apnea-hypopnea index, oxygen desaturation index, and sleep arousals. Various therapeutic modalities, including selective unilateral or bilateral HGNS, targeted unilateral HGNS, and whole unilateral or bilateral HGNS, are discussed. This review consolidates our understanding of HGNS mechanisms, fostering exploration of under-investigated outcomes and approaches to drive advancements in HGNS therapy.

neurosciences,clinical neurology
P031 A Novel Oral Appliance Implementation Protocol Using Nightly Portable Monitoring for OSA Patients Failing CPAP therapy

I Ling,J Christoforou,G Chin,P Currie

DOI: https://doi.org/10.1093/sleepadvances/zpad035.116

2023-10-01

SLEEP Advances

Abstract:Abstract Introduction Oral Appliance Therapy (OAT) is an effective second line treatment for OSA. However, OAT devices do not have active efficacy monitoring, hence little is known about methods to best identify the optimal degree of mandibular advancement. Methods Consecutive OSA patients undergoing OAT at a sleep disorders service were recruited to participate in a novel titration protocol using nightly monitoring via a portable device (NightOwl®, Ectosense, Belgium). Demographic & sleep study (PSG) data, and key NightOwl® metrics were collected. A treatment PSG was conducted at conclusion of OAT implementation using identified optimal point of mandibular advancement. Results 80 subjects were recruited (52 male, 65%) with mean (±SD) age 49±12 years, BMI 28±4.4 kg/m2, Epworth score (ESS) 9.1±4.9. Baseline PSG showed mean AHI 28±20 events/hr, nadir SpO2 84±21%, time SpO2<90% 8.3±30 minutes. Blood pressure monitoring at baseline showed mean day BP 123/70mmHg and night BP 106/57mmHg. The mean mandibular advancement implemented was 2.9±1.7mm. Post treatment mean ESS was 5.1±3.5 (p<0.001). 62/68 (91%) subjects reported perceived benefit on OAT, 49/53 (92%) reduced snoring, 51/62 (82%) improved sleep, 49/62 (79%) increased energy. Treatment PSG on completion of the protocol showed AHI 14±10 events/hr (p<0.001), nadir SpO2 82±33% (p>0.05), time SpO2<90% 1.2±21 minutes (p=0.04). 48/63 (76%) met the AHI definition of OAT success. Discussion This study demonstrates a novel OAT protocol which led to minimal degree of mandibular advancement, resulting in high rates of symptom benefit and effective treatment of OSA.
Role of Oral Appliances in the Management of Sleep Disorders

B Jayan,BNBM Prasad,RK Dhiman

DOI: https://doi.org/10.1016/s0377-1237(09)80123-8

2009-04-01

Medical Journal Armed Forces India

Abstract:BACKGROUND: A study was undertaken with the aim to evaluate the therapeutic and clinical efficacy of oral appliances in the management of upper airway sleep disorders like snoring and obstructive sleep apnea (OSA).METHODS: Oral appliances were prescribed in eight cases of non - apneic snoring and 42 polysomnography (PSG) diagnosed cases of OSA. The cases were assessed on Epworth Sleepiness Scale (ESS) and Apnea - Hypopnea Index (AHI).RESULT: 62.5% of the non - apneic snoring cases reported gross reduction/cessation of snoring. In the OSA cases, the mean AHI and ESS scores decreased from 51.48 ± 23.70 to 32.78 ± 18.06 and 12.50 ± 3.57 to 7.20 ± 2.917 respectively. A statistically significant (p<0.0001) improvement in AHI and ESS scores was observed.CONCLUSION: Short term therapeutic efficacy of oral appliances therapy in non-apneic snoring and OSA cases was observed.
Long-term Therapeutic Efficacy of Oral Appliances in Treatment of Obstructive Sleep Apnea-Hypopnea Syndrome

Xu Gong,Jingling Zhang,Ying Zhao,Xuemei Gao

DOI: https://doi.org/10.2319/060412-463.1

IF: 4.842

2015-01-01

Sleep Medicine

Abstract:Objective: To investigate the long-term efficacy and safety of oral appliances (OAs) in treating obstructive sleep apnea-hypopnea syndrome (OSAHS) by length of treatment.Materials and Methods: This is a retrospective study to review the usage of OAs in Chinese OSAHS patients in recent decades. Ninety-four valid questionnaires were returned by 412 patients with OSAHS receiving OA treatment. Among the wearers, 22 agreed to follow-up polysomnography, and 25 agreed to follow-up cephalograms. Tolerance and side effects of OAs were assessed by a survey. Comparisons of efficacy were carried out between the initial and follow-up polysomnography measurements. Cephalometric analysis was used to investigate skeletal and occlusal changes to determine safety of the OAs.Results: The longest treatment extended to 147 months, with a median of 74 months (first and third quartiles, 30 and 99 months, respectively). Among the participants, 14.9% had been treated for more than 120 months. Side effects were temporary and relatively minimal and included tooth soreness (37.2%), dry mouth (33.0%), odd bite feeling (31.9%), and excess salivation (30.8%). Polysomnography proved that OAs remained effective for the treatment of OSAHS in the long term; initial Apnea-Hypopnea Index values were reduced from a median of 24.50 (quartiles, 14.65, 54.05) without the OA to 7.40 with the OA (2.12, 10.00), and follow-up median values were 25.55 without the OA (11.71, 43.65) and 4.25 with the OA (1.38, 7.70). Cephalometric analysis indicated mild and slow changes in the skeleton and occlusion after average treatment duration of 5 years.Conclusion: OAs provided effective and safe long-term therapy for patients with OSAHS. Followup supervision is recommended since long-term alterations take place, although these appear to be minimal.
Evaluation and Management of Adults with Obstructive Sleep Apnea Syndrome

Janet J. Lee,Krishna M. Sundar

DOI: https://doi.org/10.1007/s00408-021-00426-w

2021-03-13

Lung

Abstract:Obstructive sleep apnea syndrome (OSAS) is a common and underdiagnosed medical condition characterized by recurrent sleep-dependent pauses and reductions in airflow. While a narrow, collapsible oropharynx plays a central role in the pathophysiology of OSAS, there are other equally important nonanatomic factors including sleep-stage dependent muscle tone, arousal threshold, and loop gain that drive obstructive apneas and hypopneas. Through mechanisms of intermittent hypoxemia, arousal-related sleep fragmentation, and intrathoracic pressure changes, OSAS impacts multiple organ systems. Risk factors for OSAS include obesity, male sex, age, specific craniofacial features, and ethnicity. The prevalence of OSAS is rising due to increasing obesity rates and improved sensitivity in the tools used for diagnosis. Validated questionnaires have an important but limited role in the identification of patients that would benefit from formal testing for OSA. While an in-laboratory polysomnography remains the gold standard for diagnosis, the widespread availability and accuracy of home sleep apnea testing modalities increase access and ease of OSAS diagnosis for many patients. In adults, the most common treatment involves the application of positive airway pressure (PAP), but compliance continues to be a challenge. Alternative treatments including mandibular advancement device, hypoglossal nerve stimulator, positional therapies, and surgical options coupled with weight loss and exercise offer possibilities of an individualized personal approach to OSAS. Treatment of symptomatic patients with OSAS has been found to be beneficial with regard to sleep-related quality of life, sleepiness, and motor vehicle accidents. The benefit of treating asymptomatic OSA patients, particularly with regard to cardiovascular outcomes, is controversial and more data are needed.

respiratory system
Dentoskeletal changes of long‐term oral appliance treatment in patients with obstructive sleep apnea: A systematic review and meta‐analysis

Yanlong Chen,Abdalgader I. Alhozgi,Fernanda R. Almeida

DOI: https://doi.org/10.1111/jopr.13946

2024-09-28

Journal of Prosthodontics

Abstract:Purpose This systematic review and meta‐analysis aimed to evaluate the dental and skeletal effects of the long‐term oral appliance (OA) treatment in patients with obstructive sleep apnea (OSA) and provide insights for clinicians in treatment planning and decision‐making for OSA patients undergoing OA treatment. Materials and Methods A comprehensive literature search was conducted in major databases up to April 2024. Studies were included if they assessed long‐term OA treatment (≥6 months) in adults with OSA using any type of mandibular advancement device (MADs) or tongue retaining device (TRD). Dental and skeletal changes, measured by dental cast and cephalometric analysis, were the primary outcomes. Results A total of 42 studies were included in the systematic review, with 23 included in the meta‐analysis. Long‐term OA treatment was associated with a significant decrease in overbite (0.87 mm, 95% CI: 0.69–1.05) and overjet (0.86 mm, 95% CI: 0.69–1.03). Subgroup analyses showed the decrease of overbite and overjet progressively changed over the years intervals. There was a significant retroclination of the upper incisors (U1‐SN, 2.58°, 95% CI: 1.07–4.08) and proclination of the lower incisors (L1‐MP, ‐2.67° (95% CI: ‐3.78–1.56). Skeletal changes were not significant. Conclusion Overbite and overjet gradually decreased in the long‐term OA treatment, which might predominantly result from the retroclination of the upper incisors and the proclination of the lower incisors. The skeletal patterns in the anteroposterior and vertical direction might remain relatively stable over time. There was a tendency for the clockwise rotation of the mandible.

dentistry, oral surgery & medicine
Efficacy of a Trial Oral Appliance in OSAS Management: A New Protocol to Recognize Responder/Nonresponder Patients

Marzia Segù,Alessia Cosi,Antonio Santagostini,Andrea Scribante

DOI: https://doi.org/10.1155/2021/8811700

2021-06-17

International Journal of Dentistry

Abstract:Oral appliances (OAs) of various types have shown variable success in the treatment of mild-to-moderate obstructive sleep apnoea (OSA). In an OSA sample, this study evaluated the efficacy of a diagnostic trial OA (myTAPTM); the efficacy of a definitive custom-fitted mandibular advancement device (MAD) (SomnoDent FlexTM); and whether a trial device can be used to distinguish treatment responder from nonresponder patients. Patients underwent overnight home sleep recordings prior to and after fitting of these appliances in order to objectively assess their sleep quality in terms of polysomnographic (PSG) respiratory measures: apnoea-hypopnoea index (AHI), oxygen desaturation index (ODI), and minimum oxygen saturation (LowSpO2). 40 patients with symptomatic OSAS were enrolled, 33 males and 7 females, with a mean age of 55.6 ± 12.73 years and an initial (T0) AHI of 26.51 ± 14.79. Trial devices were used in 16 patients (AHI: 29.9 ± 19.97, ODI: 21.06 ± 16.05, and LowSpO2: 82 ± 10.22 at T0) and definitive MADs in 28 (AHI: 23.90 ± 9.19, ODI: 16.27 ± 11.34, and LowSpO2: 82.87 ± 6.04 at T0). Statistically significant decreases in AHI (9.59 ± 8.94, p < 0.0023 ) and ODI (8.20 ± 9.67, p < 0.0129 ) were observed after treatment with the trial device. Only 8 of the patients in the trial device group went on to use the definitive device. Treatment with the definitive MAD produced statistically significant decreases in AHI (11.46 ± 9.65, p < 0.0001 ) and ODI (9.10 ± 8.47, p < 0.0016 ) and a significant improvement in LowSpO2 (85.09 ± 6.86, p < 0.0004 ). Thus, both types of device proved effective in improving the PSG parameters. This study showed that introducing an easy-to-make and low-cost trial device into the therapeutic pathway of OSAS patients can circumvent the problem of individual responses to treatment by allowing effective classification of patients: in short, it allows a first distinction to be drawn between responders and nonresponders to treatment.
Continuous positive airways pressure for obstructive sleep apnoea in adults

T L Giles,T J Lasserson,B J Smith,J White,J Wright,C J Cates

DOI: https://doi.org/10.1002/14651858.CD001106.pub2

2006-01-25

Abstract:Background: Obstructive sleep apnoea is the periodic reduction (hypopnoea) or cessation (apnoea) of breathing due to narrowing or occlusion of the upper airway during sleep. The main symptom is daytime sleepiness and it has been suggested it is linked to premature death, hypertension, ischaemic heart disease, stroke and road traffic accidents. Objectives: The main treatment for sleep apnoea is with the use of continuous positive airways pressure (CPAP), which requires a flow generator and mask. These are used at night to prevent apnoea, hypoxia and sleep disturbance. The objective was to assess the effects of CPAP in the treatment of obstructive sleep apnoea in adults. Search strategy: We searched the Cochrane Airways Group Trials Register and reference lists of articles. We consulted experts in the field. Searches were current to July 2005. Selection criteria: We included randomised trials comparing nocturnal CPAP with an inactive control or oral appliances in adults with obstructive sleep apnoea (an apnoea and hypopnoea index greater than five per hour). Trials had a minimum intervention period of two weeks. Data collection and analysis: Trial quality was assessed and two review authors extracted data independently. Study authors were contacted for missing information. Parallel and crossover group trials were analysed separately. Main results: Thirty-six trials involving 1718 people met the inclusion criteria. Study quality was mixed. Compared with control, CPAP showed significant improvements in objective and subjective sleepiness and several quality of life, cognitive function and depression measures (parallel-group studies: Epworth sleepiness scale (ESS) -3.83 units, 95% CI -4.57 to -3.09; crossover studies: ESS -1.84 units, 95% CI -2.57 to -1.11). Twenty-four hour systolic and diastolic blood pressures were lower with CPAP compared with control (parallel-group trials). Compared with oral appliances, CPAP significantly reduced the apnoea and hypopnoea index (crossover studies: -7.97 events/hr, 95% CI -9.56 to -6.38) and improved sleep efficiency (crossover studies: 2.31%, 95% CI 0.02 to 4.6) and minimum oxygen saturation (4.14%, 95% CI 3.25 to 5.03). Responders to both treatments expressed a strong preference for the oral appliance. However, participants were more likely to withdraw on OA than on CPAP therapy. Authors' conclusions: CPAP is effective in reducing symptoms of sleepiness and improving quality of life measures in people with moderate and severe obstructive sleep apnoea (OSA). It is more effective than oral appliances in reducing respiratory disturbances in these people but subjective outcomes are more equivocal. Certain people tend to prefer oral appliances to CPAP where both are effective. This could be because they offer a more convenient way of controlling OSA. Short-term data indicate that CPAP leads to lower blood pressure than in controls. Long-term data are required for all outcomes in order to determine whether the initial benefits seen in short-term clinical trials persist.
Oral Health Implications of Obstructive Sleep Apnea: A Literature Review

Antonino Maniaci,Salvatore Lavalle,Riccardo Anzalone,Antonino Lo Giudice,Salvatore Cocuzza,Federica Maria Parisi,Filippo Torrisi,Giannicola Iannella,Federico Sireci,Gianluca Fadda,Mario Lentini,Edoardo Masiello,Luigi La Via

DOI: https://doi.org/10.3390/biomedicines12071382

IF: 4.757

2024-06-22

Biomedicines

Abstract:Background: Obstructive sleep apnea (OSA) is a prevalent sleep disorder characterized by repeated episodes of partial or complete obstruction of the upper airway during sleep. While the systemic implications of OSA are well documented, the dental consequences are less frequently discussed yet equally significant. This review aims to elucidate the oral health impacts of OSA, emphasizing the importance of interdisciplinary care. Methods: A comprehensive literature search was conducted across several databases to identify studies examining the relationship between OSA and various oral health parameters. The review included observational studies, clinical trials, and systematic reviews published in English up to January 2024. Results: OSA was significantly associated with heightened risks of bruxism, dry mouth, periodontal disease, temporomandibular joint disorders, palatal and dental changes, and alterations in taste sensation. Mouth breathing associated with OSA was a critical factor in exacerbating xerostomia and dental caries. Furthermore, the systemic inflammation induced by OSA appeared to correlate with the severity of periodontal disease. Patients using oral appliance therapy for OSA also showed notable changes in dental occlusion and required ongoing dental monitoring. Conclusions: The findings underscore the bidirectional relationship between OSA and oral health, highlighting the need for dental professionals to be integral participants in the management of OSA. Early dental evaluation and intervention can contribute to the overall health and quality of life of individuals with OSA. The review advocates for the development of clinical guidelines to facilitate the early identification and management of OSA-related oral health issues within dental practice and encourages a collaborative approach to patient care.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy

Review of: Allemang, Dean and Hendler, James. Semantic Web for the working ontologist: modeling in RDF, RDFS and OWL. Burlington, MA: Morgan Kaufmann, 2008

Oral Appliance Treatment for Obstructive Sleep Apnea: An Update

Theory of zeta potential measurement

Evaluation of Orthodontic Treatment Modalities for Obstructive Sleep Apnoea: A Systematic Review

0607 Update on Observational Restrospective Study of the Efficacy of Oral Appliance Therapy for Obstructive Sleep Apnea

Ligand affinities in mutant metmyoglobins.

A Systematic Review of Oral Modifications Caused by the Prolonged Application of Continuous Positive Airway Pressure (CPAP) and Intraoral Appliances in Patients with Obstructive Sleep Apnea (OSA)

Interdisciplinary Role of Orthodontist in Screening and Managing Obstructive Sleep Apnea in Children and Adults

Obstructive Sleep Apnea in Adults and Ear, Nose, and Throat (ENT) Health: A Narrative Review

Clinical and Research Solutions to Manage Obstructive Sleep Apnea: A Review

0548 A 5-year Multi-center Real-world Study Evaluating the Effectiveness and Use of CAD/CAM 3D-printed OAT to Treat OSA

Orthodontics and Obstructive Sleep Apnea: A Comprehensive Study of Airway Effects and Treatment Approaches

Exploring hypoglossal nerve stimulation therapy for obstructive sleep apnea: A comprehensive review of clinical and physiological upper airway outcomes

P031 A Novel Oral Appliance Implementation Protocol Using Nightly Portable Monitoring for OSA Patients Failing CPAP therapy

Role of Oral Appliances in the Management of Sleep Disorders

Long-term Therapeutic Efficacy of Oral Appliances in Treatment of Obstructive Sleep Apnea-Hypopnea Syndrome

Evaluation and Management of Adults with Obstructive Sleep Apnea Syndrome

Dentoskeletal changes of long‐term oral appliance treatment in patients with obstructive sleep apnea: A systematic review and meta‐analysis

Efficacy of a Trial Oral Appliance in OSAS Management: A New Protocol to Recognize Responder/Nonresponder Patients

Continuous positive airways pressure for obstructive sleep apnoea in adults

Oral Health Implications of Obstructive Sleep Apnea: A Literature Review